| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |